Results 101 to 110 of about 8,104 (211)

Tiotropium Respimat inhaler and the risk of death in COPD

, 2013
Tiotropium delivered at a dose of 5 μg with the Respimat inhaler showed efficacy similar to that of 18 μg of tiotropium delivered with the HandiHaler inhalation device in placebo-controlled trials involving patients with chronic obstructive pulmonary ...
Kattenbeck, Sabine, Pledger, Gordon, Joseph, Elizabeth, Koenen-Bergmann, Michael, Dusser, Daniel, McGarvey, Lorcan, Calverley, Peter, Cotton, Daniel, Devins, Theresa, Dahl, Ronald, Wise, Robert A, Anzueto, Antonio, Disse, Bernd   +12 more
core   +1 more source

Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data

, 2015
Ha Youn Lee,1,2 Sun Mi Choi,1,2 Jinwoo Lee,1,2 Young Sik Park,1,2 Chang-Hoon Lee,1,2 Deog Kyeom Kim,2,3 Sang-Min Lee,1,2 Ho Il Yoon,2,4 Jae-Joon Yim,1,2 Young Whan Kim,1,2 Sung Koo Han,1,2 Chul-Gyu Yoo1,2 1Division of Pulmonary and Critical Care ...
Park YS, Lee SM, Lee CH, Han SK, Yoo CG, Lee HY, Lee J, Yim JJ, Kim YW, Kim DK, Choi SM, Yoon HI   +11 more
core  

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients

International Journal of COPD, 2008
Steven Kesten1, Richard Casaburi2, David Kukafka3, Christopher B Cooper41Boehringer Ingelheim GmbH, Ingelheim, Germany; 2Harbor-UCLA Medical Center, Torrance, CA, USA; 3Northern Colorado Pulmonary Consultants PC, Fort Collins, CO, USA; 4UCLA School of ...
Steven Kesten, Richard Casaburi, David Kukafka, Christopher B Cooper   +3 more
doaj  

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study

, 2018
Masakazu Ichinose,1 Masaharu Nishimura,2 Manabu Akimoto,3 Yasuhiro Kurotori,3 Yihua Zhao,4 Alberto de la Hoz,5 Michiaki Mishima6 1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Department of Pulmonary ...
Akimoto M, de la Hoz A, Nishimura M, Mishima M, Kurotori Y, Ichinose M, Zhao Y   +6 more
core  

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age

, 2016
Gary T Ferguson,1 Jill P Karpel,2 Emmanuelle Clerisme-Beaty,3 Lars Grönke,4 Florian Voß,4 Roland Buhl5 1Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, 2North Shore Medical Arts LLP, Great Neck, NY, 3Boehringer ...
Ferguson GT, Buhl R, Grönke L, Voß F, Karpel JP, Clerisme-Beaty E   +5 more
core  

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies

, 2010
Eric Bateman1, Dave Singh2, David Smith3, Bernd Disse4, Lesley Towse5, Dan Massey5, Jon Blatchford5, Demetri Pavia5, Rick Hodder61Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; 2University Hospital of ...
et al, Eric Bateman, Dave Singh, David Smith   +3 more
core  

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study

International Journal of COPD, 2019
Yoshiaki Minakata,1 Takashi Motegi,2 Jun Ueki,3 Yasuhiro Gon,4 Shuhei Nakamura,5 Tatsuhiko Anzai,6 Kazuto Hirata,7 Masakazu Ichinose81Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Wakayama, Japan; 2Department of ...
Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M   +7 more
doaj  

Tiotropium - Advancing the treatment of COPD

, 2008
Inhaled anticholinergic bronchodilators are a treatment of choice for chronic obstructive pulmonary disease (COPD). Tiotropium is currently the only long-acting inhaled anticholinergic bronchodilator available and works by selectively inhibiting ...
Tallia, AF, Stevens, R, Rasmussen, J, Gaw, A, Barakat, K, Dalrymple, J, Elward, K, Halpin, D, Schachter, M, North, F, LeFevre, M, Tamargo, J, Spann, S, Waller, D, Morrell, J, Uden, D, Kassianos, G, Kirby, M, Waite, M, Ganiats, T, Yawn, R, Price, D, Brown, P, Chambers, S, Yawn, B   +24 more
core  

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD

International Journal of COPD, 2016
Eric Derom, Guy G Brusselle, Guy F Joos Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAbstract: Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-
Derom E, Brusselle GG, Joos GF
doaj  

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD

, 2008
A-B Tonnel1, T Perez1, J-M Grosbois2, C Verkindre2, M-L Bravo3, M Brun3 on behalf of the TIPHON study groupa1Centre Hospitalier Régional Universitaire (CHRU) de Lille, Lille Cedex, France; 2Centre Hospitalier de Béthune, B& ...
M-L Bravo, J-M Grosbois, A-B Tonnel, C Verkindre, et al, T Perez   +5 more
core